Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib-Reference-Cited by-同舟云学术

Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib

Published:2014-05-30 Issue:10 Volume:53 Page:1413-1422
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Beuselinck Benoit,Lambrechts Diether,Van Brussel Thomas,Wolter Pascal,Cardinaels Nina,Joniau Steven,Lerut Evelyne,Karadimou Alexandra,Couchy Gabrielle,Sebe Philippe,Ravaud Alain,Zerbib Marc,Caty Armelle,Paridaens Robert,Schöffski Patrick,Verkarre Virginie,Berger Julien,Patard Jean-Jacques,Zucman-Rossi Jessica,Oudard Stéphane

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2014.918276

Reference22 articles.

1. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

2. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

3. Resistance to targeted therapy in renal-cell carcinoma

4. A Population Pharmacokinetic Meta-analysis of Sunitinib Malate (SU11248) and Its Primary Metabolite (SU12662) in Healthy Volunteers and Oncology Patients

5. Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Functioning Pancreatic Neuroendocrine Tumors;Neuroendocrine Tumours;2024

2. Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinoma;Cancer Drug Resistance;2023-12-28

3. Association of the 1236C>T variant of the multidrug resistance 1 gene with esophageal squamous cell carcinoma development and prognosis;Human Gene;2023-02

4. Novel Targets in Development for Advanced Renal Cell Carcinoma;Integrating Multidisciplinary Treatment for Advanced Renal Cell Carcinoma;2023

5. Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib;Cancers;2022-06-08